financetom
Market
financetom
/
Market
/
US Equity Investors to Focus on Fed's 2025 Rates Guidance This Week Amid 'Recent Strength' in Economy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Equity Investors to Focus on Fed's 2025 Rates Guidance This Week Amid 'Recent Strength' in Economy
Dec 16, 2024 3:57 AM

06:37 AM EST, 12/16/2024 (MT Newswires) -- US equity investors will watch out for the Federal Reserve's policy statement this week, looking for views on the path ahead for interest rates this year as the recent price data sparked a debate over the strength of the disinflationary trend.

* Last week, the headline and core consumer price index rose in November, matching expectations. For the producer price index, the data came in hotter than forecast, abetting concern the Fed will pause its easing cycle after its widely anticipated 25 basis-point cut on Wednesday for December.

* The probability of a rate cut in January has fallen to 17%, down from Friday, a week, and a month ago, the FedWatch Tool data showed early Monday.

* The highest probability for rates a year from now is 3.75% to 4%, versus the current 4.5% to 4.75%. "Recent strength in the US economy, including prices and wage figures, lends toward a higher for longer bias," Scotiabank said in a note Friday.

* Apart from the focus on the Fed's updated Summary of Economic Projections and Chair Jerome Powell's press briefing on Wednesday, the focus will also be on retail sales on Tuesday. The Fed's preferred inflation data, the Personal Consumer Expenditures Price index is due Friday, after the policy decision for December, undermining its importance because more economic data will be out before the Fed's next meeting on Jan. 29.

* Scotiabank said the "massive uncertainty" surrounding the Trump administration's policies relating to tariffs, regulatory change, immigration policy shifts, and net fiscal policy shifts on tax and spending combined means that investors will focus on how the FOMC shifts on Jan. 29 -- nine days after the Presidential inauguration day -- and the next SEP and dot plot in March.

* Investors will watch government bond yields closely, as the US 10-year Treasury yield jumped to 4.39% on Friday from 4.14% a week ago, its highest in three weeks, due in part to the uncertainty surrounding the strength of the US disinflationary trend.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TSX Down Near 100 Points at Midday
TSX Down Near 100 Points at Midday
Dec 27, 2024
12:18 PM EST, 12/27/2024 (MT Newswires) -- The Toronto Stock Exchange is down near 100 points at midday with energy (+0.26%) the sole gainer. Technology and miners are the biggest decliners, down 1.6% and 1%, respectively. Ned Davis Research has published a noted entitled 'Breadth noise and trouble in the background'. In it, the research cited as key takeaways: poor...
Exchange-Traded Funds, US Equities Slip After Midday Trading
Exchange-Traded Funds, US Equities Slip After Midday Trading
Dec 27, 2024
01:13 PM EST, 12/27/2024 (MT Newswires) -- Broad Market Indicators Broad-market exchange-traded funds IWM and IVV declined. Actively traded Invesco QQQ Trust (QQQ) fell 2%. US benchmark stock indexes traded lower after midday Friday amid declines in the technology sector. Energy iShares US Energy ETF (IYE) and Energy Select Sector SPDR (XLE) lost about 0.4% each. Technology Technology Select Sector...
Top Midday Decliners
Top Midday Decliners
Dec 27, 2024
01:10 PM EST, 12/27/2024 (MT Newswires) -- 180 Life Sciences ( ATNF ) priced a $2.9 million at-the-market direct offering of stock and warrants and a concurrent private placement, the biotechnology company said on Friday. 180 Life Science issued 1.2 million shares priced at $2.41 apiece along an equal number of warrants exercisable anytime over the next 66 months at...
Top Midday Gainers
Top Midday Gainers
Dec 27, 2024
12:54 PM EST, 12/27/2024 (MT Newswires) -- Vaxart ( VXRT ) said on Friday it secured a $4.6 million increase in funding under a project agreement supported by the Biomedical Advanced Research and Development Authority, raising the estimated ceiling for a mid-stage trial of its oral pill COVID-19 vaccine candidate to about $460.7 million. Vaxart ( VXRT ) shares recently...
Copyright 2023-2025 - www.financetom.com All Rights Reserved